Gene and cell therapy (GCT) has the potential to transform medicine, providing long term and potentially curative treatment options for a wide range of diseases. AAV vector is the most widely used vehicle in delivering gene of interest (GOI) in in vivo gene therapies.
GenScript ProBio is aimed to solve difficulties in producing AAV vector, and is expanding its business into AAV services to cover various needs from research through IND application to clinical trials.
Adopting most relevant GMP features, ProAAV fulfills your expectation in non-clinical phases.
Covering the process development, analytical development, GMP manufacturing and stability; supporting regulatory filings.